BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 34257563)

  • 1. Improvement in Lung Cancer Survival: 6-Year Trends of Overall Survival at Hungarian Patients Diagnosed in 2011-2016.
    Bogos K; Kiss Z; Tamási L; Ostoros G; Müller V; Urbán L; Bittner N; Sárosi V; Vastag A; Polányi Z; Nagy-Erdei Z; Daniel A; Vokó Z; Nagy B; Horváth K; Rokszin G; Abonyi-Tóth Z; Barcza Z; Gálffy G; Moldvay J
    Pathol Oncol Res; 2021; 27():603937. PubMed ID: 34257563
    [No Abstract]   [Full Text] [Related]  

  • 2. Age and Gender Specific Lung Cancer Incidence and Mortality in Hungary: Trends from 2011 Through 2016.
    Tamási L; Horváth K; Kiss Z; Bogos K; Ostoros G; Müller V; Urbán L; Bittner N; Sárosi V; Vastag A; Polányi Z; Nagy-Erdei Z; Daniel A; Nagy B; Rokszin G; Abonyi-Tóth Z; Moldvay J; Vokó Z; Gálffy G
    Pathol Oncol Res; 2021; 27():598862. PubMed ID: 34257553
    [No Abstract]   [Full Text] [Related]  

  • 3. Worse lung cancer outcome in patients with lower respiratory tract infection confirmed at time of diagnosis.
    Nagy A; Müller V; Kolonics-Farkas AM; Eszes N; Vincze K; Horvath G
    Thorac Cancer; 2019 Sep; 10(9):1819-1826. PubMed ID: 31317672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
    ; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
    Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significant Regional Differences in Lung Cancer Incidence in Hungary: Epidemiological Study Between 2011 and 2016.
    Gálffy G; Vastag A; Bogos K; Kiss Z; Ostoros G; Müller V; Urbán L; Bittner N; Sárosi V; Polányi Z; Nagy-Erdei Z; Daniel A; Knollmajer K; Várnai M; Szegner P; Vokó Z; Nagy B; Horváth K; Rokszin G; Abonyi-Tóth Z; Pozsgai É; Barcza Z; Moldvay J; Tamási L
    Pathol Oncol Res; 2021; 27():1609916. PubMed ID: 34594159
    [No Abstract]   [Full Text] [Related]  

  • 6. Causes of Death and Hospitalization in Long-term Lung Cancer Survivors: A Population-based Appraisal.
    Wu GX; Ituarte PHG; Ferrell B; Sun V; Erhunmwunsee L; Raz DJ; Kim JY
    Clin Lung Cancer; 2020 May; 21(3):204-213. PubMed ID: 31591032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lung cancer recurrence and mortality outcomes over a 10-year period using a multidisciplinary team approach.
    Nemesure B; Albano D; Bilfinger T
    Cancer Epidemiol; 2020 Oct; 68():101804. PubMed ID: 32896806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disparate outcomes in nonsmall cell lung cancer by immigration status.
    Chau B; Ituarte PH; Shinde A; Li R; Vazquez J; Glaser S; Massarelli E; Salgia R; Erhunmwunsee L; Ashing K; Amini A
    Cancer Med; 2021 Apr; 10(8):2660-2667. PubMed ID: 33734614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance and adjuvant chemotherapy survival benefits of a solid or micropapillary pattern in patients with resected stage IB lung adenocarcinoma.
    Qian F; Yang W; Wang R; Xu J; Wang S; Zhang Y; Jin B; Yu K; Han B
    J Thorac Cardiovasc Surg; 2018 Mar; 155(3):1227-1235.e2. PubMed ID: 29223834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Italian cancer figures, report 2012: Cancer in children and adolescents.
    ; ;
    Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic impacts of extracranial metastasis on non-small cell lung cancer with brain metastasis: A retrospective study based on surveillance, epidemiology, and end results database.
    Wang M; Wu Q; Zhang J; Qin G; Yang T; Liu Y; Wang X; Zhang B; Wei Y
    Cancer Med; 2021 Jan; 10(2):471-482. PubMed ID: 33320433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significant changes in advanced lung cancer survival during the past decade in Hungary: impact of modern immunotherapy and the COVID-19 pandemic.
    Kiss Z; Gálffy G; Müller V; Moldvay J; Sárosi V; Pápai-Székely Z; Csada E; Kerpel-Fronius A; Király Z; Szász Z; Hódi G; Polányi Z; Kovács K; Karamousouli E; Knollmajer K; Szabó TG; Berta A; Vokó Z; Rokszin G; Abonyi-Tóth Z; Barcza Z; Tamási L; Bogos K
    Front Oncol; 2023; 13():1207295. PubMed ID: 37860193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Revising Incidence and Mortality of Lung Cancer in Central Europe: An Epidemiology Review From Hungary.
    Bogos K; Kiss Z; Gálffy G; Tamási L; Ostoros G; Müller V; Urbán L; Bittner N; Sárosi V; Vastag A; Polányi Z; Nagy-Erdei Z; Vokó Z; Nagy B; Horváth K; Rokszin G; Abonyi-Tóth Z; Moldvay J
    Front Oncol; 2019; 9():1051. PubMed ID: 31709174
    [No Abstract]   [Full Text] [Related]  

  • 14. Increase in the Length of Lung Cancer Patient Pathway Before First-Line Therapy: A 6-Year Nationwide Analysis From Hungary.
    Kiss Z; Bogos K; Tamási L; Ostoros G; Müller V; Urbán L; Bittner N; Sárosi V; Vastag A; Polányi Z; Nagy-Erdei Z; Knollmajer K; Várnai M; Nagy B; Horváth K; Rokszin G; Abonyi-Tóth Z; Barcza Z; Moldvay J; Gálffy G; Vokó Z
    Pathol Oncol Res; 2021; 27():1610041. PubMed ID: 35002544
    [No Abstract]   [Full Text] [Related]  

  • 15. Long-term survival analysis of patients with non-small cell lung cancer complicated with type 2 diabetes mellitus.
    Wang G; Li X; Xiong R; Wu H; Xu M; Xie M
    Thorac Cancer; 2020 May; 11(5):1309-1318. PubMed ID: 32190995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Care and Outcomes of Older Persons with Lung Cancer in England and the United States, 2008-2012.
    Andreano A; Peake MD; Janes SM; Valsecchi MG; Pritchard-Jones K; Hoag JR; Gross CP
    J Thorac Oncol; 2018 Jul; 13(7):904-914. PubMed ID: 29727739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Population-based patterns of treatment and survival for patients with stage I and II non-small cell lung cancer aged 65-74 years and 75 years or older.
    Driessen E; Detillon D; Bootsma G; De Ruysscher D; Veen E; Aarts M; Janssen-Heijnen M
    J Geriatr Oncol; 2019 Jul; 10(4):547-554. PubMed ID: 30876833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lung adenocarcinoma with intraoperatively diagnosed pleural seeding: Is main tumor resection beneficial for prognosis?
    Li C; Kuo SW; Hsu HH; Lin MW; Chen JS
    J Thorac Cardiovasc Surg; 2018 Mar; 155(3):1238-1249.e1. PubMed ID: 29254636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metformin use and lung cancer survival: a population-based study in Norway.
    Brancher S; Støer NC; Weiderpass E; Damhuis RAM; Johannesen TB; Botteri E; Strand TE
    Br J Cancer; 2021 Mar; 124(5):1018-1025. PubMed ID: 33262518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overall survival according to immunotherapy and radiation treatment for metastatic non-small-cell lung cancer: a National Cancer Database analysis.
    Foster CC; Sher DJ; Rusthoven CG; Verma V; Spiotto MT; Weichselbaum RR; Koshy M
    Radiat Oncol; 2019 Jan; 14(1):18. PubMed ID: 30691492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.